title: Prevalence of hepatitis A virus infection in Afro-Brazilian isolated communities in Central Brazil.
abstract: To investigate hepatitis A virus (HAV) infection rates among isolated African-descendant communities in Central Brazil, 947 subjects were interviewed about demographic characteristics in all 12 isolated Afro-descendant communities existing in the state of Mato Grosso do Sul, Central Brazil, between March 2002 and November 2003. Blood samples were collected and sera were tested for HAV antibodies (total and IgM anti-HAV) by enzyme-linked immunosorbent assay. The overall prevalence of HAV infection was 75.6% (95% CI: 72.7-78.3), ranging from 55.4 to 97.3%, depending on the communities studied. The prevalence of anti-HAV increased significantly with age, from 13.8% in the age 0-5 age group to 96.6% in those older than 40 years. The findings point out an intermediate endemicity of HAV infection in some Afro-Brazilian isolated communities in Central Brazil. In addition, the high proportion of susceptible young subjects could be target of future HAV vaccination programs.
authors.affiliation: Instituto de Patologia e Saúde Pública, Universidade Federal de Goiás, Goiânia, Brasil.
authors.forename: Aline G
authors.initials: AG
authors.lastname: Kozlowski
authors.forename: Ana R C
authors.initials: AR
authors.lastname: Motta-Castro
authors.forename: Laura B
authors.initials: LB
authors.lastname: Nascimento
authors.forename: Agabo M C
authors.initials: AM
authors.lastname: Silva
authors.forename: Sheila A
authors.initials: SA
authors.lastname: Teles
authors.forename: Livia M
authors.initials: LM
authors.lastname: Villar
authors.forename: Ana M C
authors.initials: AM
authors.lastname: Gaspar
authors.forename: Regina M B
authors.initials: RM
authors.lastname: Martins
mesh_terms: D000293:Adolescent; D000328:Adult; D017677:Age Distribution; D000368:Aged; D000369:Aged, 80 and over; D044383:Black People; D001938:Brazil / Q000453:epidemiology; D002648:Child; D002675:Child, Preschool; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006506:Hepatitis A / Q000175:diagnosis / Q000453:epidemiology*; D035922:Hepatitis A Antibodies / Q000097:blood*; D030041:Hepatitis A virus / Q000276:immunology*; D006801:Humans; D007223:Infant; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D016036:Seroepidemiologic Studies
chemical_list: D035922:Hepatitis A Antibodies